Clinical Neurophysiology Service, University Clinic of Navarra, Pamplona, Spain.
PLoS One. 2012;7(3):e33769. doi: 10.1371/journal.pone.0033769. Epub 2012 Mar 16.
Obstructive Sleep Apnea (OSA) is a major risk factor for cardiovascular disease. The goal of this study was to demonstrate whether the use of CPAP produces significant changes in the heart rate or in the heart rate variability of patients with OSA in the first night of treatment and whether gender and obesity play a role in these differences.
Single-center transversal study including patients with severe OSA corrected with CPAP. Only patients with total correction after CPAP were included. Patients underwent two sleep studies on consecutive nights: the first night a basal study, and the second with CPAP. We also analyzed the heart rate changes and their relationship with CPAP treatment, sleep stages, sex and body mass index. Twenty-minute segments of the ECG were selected from the sleep periods of REM, no-REM and awake. Heart rate (HR) and heart rate variability (HRV) were studied by comparing the R-R interval in the different conditions. We also compared samples from the basal study and CPAP nights.
39 patients (15 females, 24 males) were studied. The mean age was 50.67 years old, the mean AHI was 48.54, and mean body mass index was 33.41 kg/m(2) (31.83 males, 35.95 females). Our results showed that HRV (SDNN) decreased after the use of CPAP during the first night of treatment, especially in non-REM sleep. Gender and obesity did not have any influence on our results.
These findings support that cardiac variability improves as an acute effect, independently of gender or weight, in the first night of CPAP use in severe OSA patients, supporting the idea of continuous use and emphasizing that noncompliance of CPAP treatment should be avoided even if it is just once.
阻塞性睡眠呼吸暂停(OSA)是心血管疾病的主要危险因素。本研究的目的是证明 CPAP 的使用是否会在治疗的第一晚引起 OSA 患者的心率或心率变异性发生显著变化,以及性别和肥胖是否在这些差异中起作用。
单中心横断研究包括使用 CPAP 纠正的重度 OSA 患者。仅纳入 CPAP 治疗后完全纠正的患者。患者连续两晚进行两次睡眠研究:第一晚进行基础研究,第二晚进行 CPAP 治疗。我们还分析了心率变化及其与 CPAP 治疗、睡眠阶段、性别和体重指数的关系。从 REM、非 REM 和清醒睡眠期选择 20 分钟的 ECG 片段。通过比较不同条件下的 R-R 间隔来研究心率(HR)和心率变异性(HRV)。我们还比较了基础研究和 CPAP 夜间的样本。
研究了 39 名患者(15 名女性,24 名男性)。平均年龄为 50.67 岁,平均 AHI 为 48.54,平均体重指数为 33.41kg/m2(男性 31.83 名,女性 35.95 名)。我们的结果表明,CPAP 使用后的第一晚,特别是在非 REM 睡眠期间,HRV(SDNN)降低。性别和肥胖对我们的结果没有任何影响。
这些发现支持这样一种观点,即心脏变异性作为一种急性效应,在严重 OSA 患者使用 CPAP 的第一晚得到改善,这与性别或体重无关,支持持续使用的观点,并强调即使只是一次,也应避免 CPAP 治疗的不依从。